Safety for vaccine(e)s.
作者信息
Merten O W
机构信息
Généthon III; 1, Rue de l'Internationale, F-91002, Evry-Cedex, France.
出版信息
Cytotechnology. 2000 Nov;34(3):181-3. doi: 10.1023/A:1008160817560.
Abstract
摘要
相似文献
1
Safety for vaccine(e)s.
Cytotechnology. 2000 Nov;34(3):181-3. doi: 10.1023/A:1008160817560.
2
Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children.
PLoS One. 2010 Nov 29;5(11):e14090. doi: 10.1371/journal.pone.0014090.
3
Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial.
Lancet Infect Dis. 2011 Oct;11(10):741-9. doi: 10.1016/S1473-3099(11)70100-1. Epub 2011 Jul 22.
4
Impact of social media news on COVID-19 vaccine hesitancy and vaccination behavior.
Telemat Inform. 2023 May;80:101983. doi: 10.1016/j.tele.2023.101983. Epub 2023 Apr 23.
5
Assessing the safety, impact and effectiveness of RTS,S/AS01 malaria vaccine following its introduction in three sub-Saharan African countries: methodological approaches and study set-up.
Malar J. 2022 Apr 25;21(1):132. doi: 10.1186/s12936-022-04144-3.
6
Overview of U.S. COVID-19 vaccine safety surveillance systems.
Vaccine. 2024 Sep 17;42 Suppl 3:125748. doi: 10.1016/j.vaccine.2024.02.065. Epub 2024 Apr 16.
7
Safety of the RTS,S/AS02A malaria vaccine in Mozambican children during a Phase IIb trial.
Vaccine. 2008 Jan 10;26(2):174-84. doi: 10.1016/j.vaccine.2007.11.003. Epub 2007 Nov 26.
8
Formal training in vaccine safety to address parental concerns not routinely conducted in U.S. pediatric residency programs.
Vaccine. 2014 May 30;32(26):3175-8. doi: 10.1016/j.vaccine.2014.04.001. Epub 2014 Apr 13.
9
Safety, immunogenicity and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulation.
Pediatr Infect Dis J. 2003 Oct;22(10):914-20. doi: 10.1097/01.inf.0000091887.48999.77.
10
Safety profile of a replication-deficient human adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle.
Transbound Emerg Dis. 2018 Apr;65(2):447-455. doi: 10.1111/tbed.12724. Epub 2017 Oct 27.
引用本文的文献
1
Real-time monitoring of adherent Vero cell density and apoptosis in bioreactor processes.
Cytotechnology. 2012 Aug;64(4):429-41. doi: 10.1007/s10616-011-9421-2. Epub 2012 Feb 25.
2
Production of inactivated influenza H5N1 vaccines from MDCK cells in serum-free medium.
PLoS One. 2011 Jan 24;6(1):e14578. doi: 10.1371/journal.pone.0014578.
本文引用的文献
1
Evaluation of the serum-free medium MDSS2 for the production of poliovirus on vero cells in bioreactors.
Cytotechnology. 1997 Nov;25(1-3):35-44. doi: 10.1023/A:1007999313566.
2
The new medium MDSS2N, free of any animal protein supports cell growth and production of various viruses.
Cytotechnology. 1999 Jul;30(1-3):191-201. doi: 10.1023/A:1008021317639.
3
Influvac: a safe Madin Darby Canine Kidney (MDCK) cell culture-based influenza vaccine.
Dev Biol Stand. 1999;98:93-100; discussion 111.
4
An experimental rabies vaccine produced with a new BHK-21 suspension cell culture process: use of serum-free medium and perfusion-reactor system.
Vaccine. 1995 Sep;13(13):1244-50. doi: 10.1016/0264-410x(94)00022-f.
5
Beta-propiolactone treatment impairs the biological activity of residual DNA from BHK-21 cells infected with rabies virus.
Vaccine. 1993;11(1):82-90. doi: 10.1016/0264-410x(93)90343-v.
6
Protein-free culture of Vero cells: a substrate for replication of human pathogenic viruses.
Cell Biol Int. 1993 Sep;17(9):885-95. doi: 10.1006/cbir.1993.1152.
7
Ongoing tragedy of rabies.
Lancet. 1993 Oct 30;342(8879):1067-8. doi: 10.1016/0140-6736(93)92058-2.
8
[Current situation on human rabies control and anti-rabies vaccination].
Sante. 1994 May-Jun;4(3):203-4.
9
Evaluation of the new serum-free medium (MDSS2) for the production of different biologicals: use of various cell lines.
Cytotechnology. 1994;14(1):47-59. doi: 10.1007/BF00772195.
10
Industrial-scale production of inactivated poliovirus vaccine prepared by culture of Vero cells on microcarrier.
Rev Infect Dis. 1984 May-Jun;6 Suppl 2:S341-4. doi: 10.1093/clinids/6.supplement_2.s341.
Zotero 插件